instruction:
In this task, you're given a paragraph from the research paper and your task is to generate a suitable title for the research paper based on the given paper. Under 100 words is a good title length.
question:
a b s t r a c t H1N1 is an infectious virus which, when spread affects a large volume of the population. It is an airborne disease that spreads easily and has a high death rate. Development of healthcare support systems using cloud computing is emerging as an effective solution with the benefits of better quality of service, reduced costs and flexibility. In this paper, an effective cloud computing architecture is proposed which predicts H1N1 infected patients and provides preventions to control infection rate. It consists of four processing components along with secure cloud storage medical database. The random decision tree is used to initially assess the infection in any patient depending on his/her symptoms. Social Network Analysis (SNA) is used to present the state of the outbreak. The proposed architecture is tested on synthetic data generated for two million users. The system provided 94% accuracy for the classification and around 81% of the resource utilization on Amazon EC2 cloud. The key point of the paper is the use of SNA graphs to calculate role of an infected user in spreading the outbreak known as Outbreak Role Index (ORI). It will help government agencies and healthcare departments to present, analyze and prevent outbreak effectively.
answer:
Smart monitoring and controlling of Pandemic Influenza A (H1N1) using Social Network Analysis and cloud computing

question:
Viral infection induces innate immunity and apoptosis. Apoptosis is an effective means to sacrifice virus-infected host cells and therefore restrict the spread of pathogens. However, the underlying mechanisms of this process are still poorly understood. Here, we show that the mitochondrial antiviral signaling protein (MAVS/VISA/Cardif/IPS-1) is critical for SeV (Sendai virus)-induced apoptosis. MAVS specifically activates c-Jun N-terminal kinase 2 (JNK2) but not other MAP kinases. Jnk22/2 cells, but not Jnk12/2 cells, are unable to initiate virus-induced apoptosis and SeV further fails to trigger apoptosis in MAPK kinase 7 (MKK7) knockout (Mkk72/2) cells. Mechanistically, MAVS recruits MKK7 onto mitochondria via its 3D domain, which subsequently phosphorylates JNK2 and thus activates the apoptosis pathway. Consistently, Jnk22/2 mice, but not Jnk12/2 mice, display marked inflammatory injury in lung and liver after viral challenge. Collectively, we have identified a novel signaling pathway, involving MAVS-MKK7-JNK2, which mediates virus-induced apoptosis and highlights the indispensable role of mitochondrial outer membrane in host defenses.
answer:
MAVS-MKK7-JNK2 Defines a Novel Apoptotic Signaling Pathway during Viral Infection

question:
Interferon-induced transmembrane protein 3 (IFITM3) is an antiviral transmembrane protein that is thought to serve as the primary factor for inhibiting the replication of al arge number of viruses,i ncluding West Nile virus,D engue virus,Ebola virus,and Zika virus.Production of this 14.5 kDa, 133-residue transmembrane protein, especially with essential posttranslational modifications,b yr ecombinant expression is challenging.Inthis report, we document the chemical synthesis of IFTIM3 in multi-milligram quantities (> 15 mg) and the preparation of phosphorylated and fluorescent variants.T he synthesis was accomplished by using KAHA ligations,w hich operate under acidic aqueous/organic mixtures that excel at solubilizing even the exceptionally hydrophobic C-terminal region of IFITM3. The synthetic material is readily incorporated into model vesicles and forms the basis for using synthetic,h omogenous IFITM3 and its derivatives for further studying its structure and biological mode of action. Interferon-induced transmembrane protein 3( IFITM3) is a1 33 amino acid membrane-associated protein (MP) that inhibits the replication of pathogenic viruses.This protein was first named fragilis and reported by Saitou and co-workers in 2002, [1] but interest surged when its antiviral properties came to light during the 2009 H1N1 influenza pandemic. Everitt and co-workers [2] reported that patients lacking full IFITM3 were more quickly and severely infected, leading to adramatic increase in mortality.S ubsequent studies have shown that IFITM3 exhibits antiviral activity against al arge number of viruses, [3, 4] including West Nile virus, [5, 6] Dengue virus, [5] [6] [7] Filoviruses (Ebola and Marburg viruses), [8] SARS Coronavirus, [8] Rift Va lley fever virus, [9] HIV-1 [10] and, most recently, Zika virus. [11] IFITM3 and its related proteins (IFITMs) contain two highly hydrophobic intramembrane domains:aconserved loop region, and amore polar N-terminal region that varies in sequence and length (Figure 1a) . Several proposals for its structure,m embrane-spanning topology,a nd mechanism of action have been reported but there is little consensus of how IFITM3 prevents viral replication. [12] Further studies,such as structure determination and investigation of its numerous posttranslational modifications, [13] [14] [15] [16] are hampered in part by lack of access to the pure protein, especially homogeneous material containing the essential posttranslational modifications. In this report, we document the production of milligram quantities of homogeneous IFITM3 and key post-translationally modified variants by total chemical synthesis by using aketoacid-hydroxylamine (KAHA) ligation. [17] Key to the success of this work is the unique nature of the KAHA ligation using 5-oxaproline,w hich operates under acidic conditions ideal for solubilizing hydrophobic peptide segments and delivers more soluble peptide esters compared to amide as the primary ligation product. Theu se of 5-oxaproline results in the introduction of homoserine,anon-canonical amino acid, at the ligation site.W hen carefully chosen, we have found that this is an innocuous mutation of many residues and have shown that it does not disturb folding or biological activity. [18] Thes ynthetic route allows facile incorporation of key posttranslational modifications,i ncluding phosphorylation and the attachment of afluorescent dye.This work establishes access to homogenous IFITM3 and will enable further studies on its structure and mode of action. Our synthetic planning took into account the different structural regions of IFITM3 and took inspiration from amap of key residue constructed by Brass and co-workers. [7] We aimed to synthesize IFITM3 from three segments using two KAHA ligations.F or the first ligation site,w ec hose Ser50Hse,s ince this is located in an exposed loop region that shows considerable variability among IFITM proteins. As the second ligation, we selected Thr95Hse,s ince this site was reported to be one of the few variable sites within an otherwise highly conserved region. This strategy called for the use of av aline a-ketoacid for the ligation, which although somewhat slower than less hindered residues,h as proven to be an excellent choice for KAHA ligations. [18b] Thes ynthesis of segment 3, which contains the IM2 domain, proved to be the most challenging.O wing to its extreme hydrophobicity,wefirst attempted to synthesize it by tert-butyloxycarbonyl solid-phase peptide synthesis (Boc-SPPS), since Boc chemistry is known to be better suited than fluorenylmethyloxycarbonyl solid-phase peptide synthesis (Fmoc-SPPS) for the preparation of hydrophobic Supportinginformation and the ORCID identification number(s) for the author(s) of this article can be found under: https://doi.org/10.
answer:
Protein Synthesis Chemical Synthesis of the Highly Hydrophobic Antiviral Membrane- Associated Protein IFITM3 and Modified Variants Communications